Generic Injectables Market Scope And Analysis

  • Report Code : TIPRE00004765
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 217
Buy Now

Generic Injectables Market Analysis Report 2022 to 2028

Buy Now

Generic Injectables Market Report Generic Injectables Market Size and Share Generic Injectables Market Scope and Analysis

Generic Injectables Market Report Scope

Report Attribute Details
Market size in 2021 US$ 74.74 Billion
Market Size by 2028 US$ 150.65 Billion
Global CAGR (2021 - 2028) 10.5%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Product Type
  • Large Molecule Injectables and Small Molecule Injectables
By Container Type
  • Vials
  • Premix
  • Prefilled Syringes
  • Ampoules
By Application
  • Oncology
  • Infectious Diseases
  • Cardiology
  • Diabetes
  • Immunology
By Route of Administration
  • Intravenous
  • Intramuscular
  • Subcutaneous
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Astrazeneca
  • Baxter International Inc
  • Biocon
  • Fresenius SE Co KGaA
  • GlaxoSmithKline Plc
  • Hikma Pharmaceuticals
  • Johnson Johnson Services Inc
  • Lupin Ltd
  • Merck Co Inc

    •  

    Route of Administration-Based Insights

    Based on the route of administration, the generic injectables market has been categorized into intravenous, intramuscular, subcutaneous, and others. The intravenous segment held the largest market share in 2021.

    The generic injectables market players adopt organic strategies such as product launch and expansion to expand their footprint and product portfolio worldwide.

    By Geography

    • North America

      • US
      • Canada
      • Mexico

    • Europe

      • France
      • Germany
      • Italy
      • UK
      • Spain
      • Rest of Europe

    • Asia Pacific (APAC)

      • China
      • India
      • South Korea
      • Japan
      • Australia
      • Rest of APAC

    • Middle East & Africa (MEA)

      • South Africa
      • Saudi Arabia
      • UAE
      • Rest of MEA

    • South and Central America (SCAM)

      • Brazil
      • Argentina
      • Rest of SCAM

    Company Profiles

    • Astrazeneca
    • Baxter International, Inc.
    • Biocon
    • Fresenius SE & Co. KGaA
    • GlaxoSmithKline Plc
    • Hikma Pharmaceuticals
    • Johnson & Johnson Services, Inc.
    • Lupin, Ltd.
    • Merck & Co., Inc.
    • Mylan N.V.
    • Pfizer, Inc